Literature DB >> 10211467

Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome.

P Nichols1, R Croxen, A Vincent, R Rutter, M Hutchinson, J Newsom-Davis, D Beeson.   

Abstract

Congenital myasthenic syndrome comprises a heterogeneous group of inherited disorders of neuromuscular transmission. Acetylcholine receptor (AChR) deficiency is the most common form of congenital myasthenic syndrome and in most cases results from mutations within the coding region of the AChR epsilon subunit. However, studies in mice have established that synapse-specific expression of AChR is dependent on a sequence contained within the AChR-subunit promoter regions, termed an N-box. We describe a consanguineous family in which 2 of 7 siblings had clinical and electromyographic features consistent with AChR deficiency. Muscle biopsy demonstrated low AChR numbers, establishing the disorder as postsynaptic. Single-strand conformational polymorphism analysis identified an abnormal conformer in the AChR epsilon-subunit gene promoter of the patients. DNA sequence and restriction endonuclease analysis shows that the disorder cosegregates with recessive inheritance of a single point mutation, a transition (C-->T) in the N-box of the epsilon-subunit promoter. Analysis of an intercostal biopsy from 1 of the patients showed a dramatic reduction in epsilon-subunit mRNA levels compared with disease and normal controls. This is the first evidence in humans that an N-box mutation can lead to disruption of epsilon-subunit transcription, resulting in the loss of adult AChR synthesis and the clinical phenotype of AChR-deficiency congenital myasthenic syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211467

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

1.  The Ets transcription factor GABP is required for postsynaptic differentiation in vivo.

Authors:  A Briguet; M A Ruegg
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Targeting of the ETS factor GABPalpha disrupts neuromuscular junction synaptic function.

Authors:  Debra A O'Leary; Peter G Noakes; Nick A Lavidis; Ismail Kola; Paul J Hertzog; Sika Ristevski
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

Review 3.  Current status of the congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-11-21       Impact factor: 4.296

Review 4.  Extracellular signal-regulated kinases 1 and 2 regulate neuromuscular junction and myofiber phenotypes in mammalian skeletal muscle.

Authors:  Mendell Rimer
Journal:  Neurosci Lett       Date:  2019-12-02       Impact factor: 3.046

5.  Identification of previously unreported mutations in CHRNA1, CHRNE and RAPSN genes in three unrelated Italian patients with congenital myasthenic syndromes.

Authors:  Raffaella Brugnoni; Lorenzo Maggi; Eleonora Canioni; Isabella Moroni; Chiara Pantaleoni; Stefano D'Arrigo; Daria Riva; Ferdinando Cornelio; Pia Bernasconi; Renato Mantegazza
Journal:  J Neurol       Date:  2010-02-16       Impact factor: 4.849

Review 6.  Congenital myasthenic syndromes: genetic defects of the neuromuscular junction.

Authors:  Kinji Ohno; Andrew G Engel
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

7.  GA-binding protein is dispensable for neuromuscular synapse formation and synapse-specific gene expression.

Authors:  Alexander Jaworski; Cynthia L Smith; Steven J Burden
Journal:  Mol Cell Biol       Date:  2007-05-07       Impact factor: 4.272

8.  Regulation of the rapsyn promoter by kaiso and delta-catenin.

Authors:  Marianna Rodova; Kevin F Kelly; Michael VanSaun; Juliet M Daniel; Michael J Werle
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

9.  Expression of mutant Ets protein at the neuromuscular synapse causes alterations in morphology and gene expression.

Authors:  Alban de Kerchove D'Exaerde; Jean Cartaud; Aymeric Ravel-Chapuis; Thierry Seroz; Fabien Pasteau; Lindsay M Angus; Bernard J Jasmin; Jean-Pierre Changeux; Laurent Schaeffer
Journal:  EMBO Rep       Date:  2002-10-22       Impact factor: 8.807

10.  Phosphorylation-elicited quaternary changes of GA binding protein in transcriptional activation.

Authors:  Morten Sunesen; Monique Huchet-Dymanus; Morten O Christensen; Jean-Pierre Changeux
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.